Tandem Diabetes Care Inc (TNDM) shareholders
Close on Nov 17, 2026Market cap $1.19BP/E –Yield –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| BlackRock, Inc. | 10,106,682 | 15.20% | 13G (passive) amendment | Mar 31, 2025 |
| Sessa Capital IM GP, LLC Joint filing with Sessa Capital (Master), L.P. (6.71%), Sessa Capital GP, LLC (6.71%) and 2 more | 4,466,307 | 6.71% | 13G (passive) | Mar 31, 2025 |
| Goldman Sachs & Co. LLC Joint filing with The Goldman Sachs Group, Inc. (5.90%) | 4,091,935 | 5.90% | 13G (passive) | Sep 30, 2026 |
| Vanguard Portfolio Management | 4,052,274 | 5.91% | 13G (passive) | Mar 31, 2026 |
| Vanguard Capital Management | 3,553,772 | 5.18% | 13G (passive) | Mar 31, 2026 |
| Capital World Investors | 3,265,300 | 5.00% | 13G (passive) amendment | Aug 30, 2024 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of TNDM | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| BlackRock, Inc. | 11,583,125 | 16.65% | $174.79M | +892,281 | 0.00% |
| Sessa Capital IM, L.P. | 5,100,000 | 7.33% | $76.96M | +369,243 | 1.29% |
| Vanguard Portfolio Management LLC | 4,299,667 | 6.18% | $64.88M | +306,334 | 0.00% |
| First Light Asset Management, LLC | 3,383,553 | 4.86% | $51.06M | +2,068,838 | 3.10% |
| Vanguard Capital Management LLC | 3,096,536 | 4.45% | $46.73M | +57,617 | 0.00% |
| State Street Corp | 2,851,646 | 4.10% | $43.03M | +189,386 | 0.00% |
| GW&K Investment Management, LLC | 2,569,032 | 3.69% | $38.77M | −120,074 | 0.30% |
| Jennison Associates LLC | 2,331,429 | 3.35% | $35.18M | +672,981 | 0.02% |
| Paradice Investment Management LLC | 2,024,014 | 2.91% | $30.54M | −18,411 | 4.87% |
| Jacobs Levy Equity Management, Inc | 2,006,429 | 2.88% | $30.28M | +482,483 | 0.11% |
| Freestone Grove Partners LP | 1,866,134 | 2.68% | $28.16M | +535,392 | 0.18% |
| Geode Capital Management, LLC | 1,800,797 | 2.59% | $27.18M | +120,934 | 0.00% |
| Driehaus Capital Management LLC | 1,786,996 | 2.57% | $26.97M | −517,418 | 0.16% |
| Citadel Advisors LLC | 1,735,879 | 2.49% | $26.19M | −456,788 | 0.00% |
| Millennium Management LLC | 1,311,739 | 1.89% | $19.79M | +550,067 | 0.01% |
| Woodline Partners LP | 1,307,439 | 1.88% | $19.73M | New | 0.06% |
| ArrowMark Colorado Holdings LLC | 1,299,586 | 1.87% | $19.61M | −1,804,023 | 0.82% |
| UBS Group AG | 1,146,580 | 1.65% | $17.30M | −901,221 | 0.00% |
| FMR LLC | 976,432 | 1.40% | $14.73M | +262,421 | 0.00% |
| Royce & Associates LP | 900,590 | 1.29% | $13.59M | +204,000 | 0.11% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 274 | 79M | 100.0% | 49 / 95 | 91 / 44 | 15M | 15M |
| Q1 2026 | 273 | 79M | 100.0% | 45 / 94 | 94 / 35 | 20M | 9M |
| Q4 2025 | 268 | 75M | 100.0% | 52 / 85 | 99 / 32 | 13M | 13M |
| Q3 2025 | 255 | 75M | 100.0% | 43 / 75 | 97 / 57 | 11M | 17M |
| Q2 2025 | 270 | 82M | 100.0% | 40 / 116 | 71 / 43 | 15M | 7M |
| Q1 2025 | 275 | 73M | 100.0% | 40 / 107 | 85 / 77 | 14M | 12M |
| Q4 2024 | 315 | 72M | 100.0% | 42 / 137 | 91 / 52 | 12M | 13M |
| Q3 2024 | 331 | 73M | 100.0% | 59 / 109 | 117 / 41 | 20M | 9M |
| Q2 2024 | 316 | 74M | 100.0% | 63 / 124 | 91 / 35 | 11M | 14M |
| Q1 2024 | 291 | 77M | 100.0% | 54 / 123 | 78 / 29 | 19M | 14M |
| Q4 2023 | 268 | 72M | 100.0% | 75 / 85 | 85 / 32 | 10M | 8M |
| Q3 2023 | 226 | 70M | 100.0% | 26 / 80 | 90 / 45 | 11M | 9M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
219 funds held TNDM in Q2 2026, 64% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.
| Fund | Shares | % of TNDM | Value | % of fund | As of |
|---|---|---|---|---|---|
| iShares Core S&P Small-Cap ETF | 4,129,585 | 5.94% | $62.32M | 0.06% | Jun 30, 2026 |
| Vanguard Total Stock Market Index Fund | 2,186,918 | 3.14% | $33.00M | 0.00% | Jun 30, 2026 |
| iShares Russell 2000 ETF | 1,818,684 | 2.61% | $27.44M | 0.03% | Jun 30, 2026 |
| Vanguard Small-Cap Index Fund | 1,570,019 | 2.26% | $23.69M | 0.01% | Jun 30, 2026 |
| Vanguard Small-Cap Growth Index Fund | 901,467 | 1.30% | $13.60M | 0.03% | Jun 30, 2026 |
| Vanguard Extended Market Index Fund | 788,509 | 1.13% | $11.90M | 0.01% | Jun 30, 2026 |
| Fidelity Small Cap Index Fund | 763,465 | 1.10% | $14.89M | 0.04% | Jul 31, 2026 |
| PGIM Jennison Health Sciences Fund | 680,031 | 0.98% | $11.70M | 0.84% | May 29, 2026 |
| iShares Russell 2000 Growth ETF | 644,820 | 0.93% | $9.73M | 0.06% | Jun 30, 2026 |
| State Street(R) SPDR(R) Portfolio S&P 600(TM) Small Cap ETF | 627,958 | 0.90% | $9.48M | 0.06% | Jun 30, 2026 |
| Meridian Growth Fund | 483,102 | 0.69% | $7.29M | 1.34% | Jun 30, 2026 |
| Strategic Advisers Fidelity U.S. Total Stock Fund | 476,900 | 0.69% | $8.20M | 0.00% | May 31, 2026 |
| Vanguard Tax-Managed Small-Cap Fund | 454,971 | 0.65% | $6.87M | 0.06% | Jun 30, 2026 |
| Royce Small-Cap Opportunity Fund | 423,694 | 0.61% | $6.39M | 0.45% | Jun 30, 2026 |
| Fidelity Enhanced Small Cap Core ETF | 360,810 | 0.52% | $5.44M | 0.09% | Jun 30, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Leigh Vosseller | EVP & CHIEF FINANCIAL OFFICER | 80,260 | 0.12% | Nov 17, 2026 |
| Rick Carpenter | EVP & Chief Technology Officer | 33,378 | 0.05% | Nov 17, 2026 |
| Jean-Claude Kyrillos | EVP & Chief Operating Officer | 32,682 | 0.05% | Nov 17, 2026 |
| Shannon Marie Hansen | EVP & Chief Legal Officer | 35,064 | 0.05% | Nov 17, 2026 |
| Susan Morrison | EVP & Chief Admin. Officer | 54,806 | 0.08% | Nov 17, 2026 |
| Elizabeth Anne Gasser | EVP, Chief Strategy Officer | 35,901 | 0.05% | Nov 17, 2026 |
| Mark David Novara | EVP & CHIEF COMMERCIAL OFFICER | 37,732 | 0.05% | May 19, 2026 |
| John F. Sheridan | Director | 168,077 | 0.24% | Nov 17, 2026 |
| Sandra Beaver | Director | 6,747 | 0.01% | Nov 17, 2026 |
| Christopher J. Twomey | Director | 37,114 | 0.05% | Oct 29, 2026 |
| Kathleen McGroddy-Goetz | Director | 26,612 | 0.04% | May 22, 2026 |
| Myoungil Cha | Director | 22,458 | 0.03% | May 22, 2026 |
| Joao Paulo Falcao Malagueira | Director | 22,458 | 0.03% | May 22, 2026 |
| Rajwant Sodhi | Director | 24,280 | 0.03% | May 22, 2026 |
| Rebecca B. Robertson | Director | 22,542 | 0.03% | May 22, 2026 |
| Peyton R. Howell | Director | 29,836 | 0.04% | May 22, 2026 |
| Kim D. Blickenstaff | Director | 183,038 | 0.26% | Nov 22, 2024 |
| Dick Allen | – | 50,903 | 0.07% | May 22, 2026 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Jean-Claude Kyrillos EVP & Chief Operating Officer | Nov 16, 2026 | Award | +207 | $11.51 | $2.38K | 32,682 |
| Leigh Vosseller EVP & CHIEF FINANCIAL OFFICER | Nov 15, 2026 | Tax withholding | −942 | $20.07 | $18.91K | 54,680 |
| Leigh Vosseller EVP & CHIEF FINANCIAL OFFICER | Nov 15, 2026 | Option exercise | +2,624 | – | – | 55,622 |
| Leigh Vosseller EVP & CHIEF FINANCIAL OFFICER | Nov 15, 2026 | Tax withholding | −537 | $20.07 | $10.78K | 52,998 |
| Leigh Vosseller EVP & CHIEF FINANCIAL OFFICER | Nov 15, 2026 | Option exercise | +1,495 | – | – | 53,535 |
| John F. Sheridan Director | Nov 15, 2026 | Tax withholding | −5,055 | $20.07 | $101.45K | 168,077 |
| John F. Sheridan Director | Nov 15, 2026 | Option exercise | +9,934 | – | – | 173,132 |
| John F. Sheridan Director | Nov 15, 2026 | Tax withholding | −3,045 | $20.07 | $61.11K | 163,198 |
| John F. Sheridan Director | Nov 15, 2026 | Option exercise | +5,983 | – | – | 166,243 |
| Susan Morrison EVP & Chief Admin. Officer | Nov 15, 2026 | Tax withholding | −496 | $20.07 | $9.95K | 54,806 |
| Susan Morrison EVP & Chief Admin. Officer | Nov 15, 2026 | Option exercise | +1,731 | – | – | 55,302 |
| Susan Morrison EVP & Chief Admin. Officer | Nov 15, 2026 | Tax withholding | −314 | $20.07 | $6.30K | 53,571 |
| Susan Morrison EVP & Chief Admin. Officer | Nov 15, 2026 | Option exercise | +1,097 | – | – | 53,885 |
| Jean-Claude Kyrillos EVP & Chief Operating Officer | Nov 15, 2026 | Tax withholding | −535 | $20.07 | $10.74K | 32,475 |
| Jean-Claude Kyrillos EVP & Chief Operating Officer | Nov 15, 2026 | Option exercise | +1,009 | – | – | 33,010 |
| Shannon Marie Hansen EVP & Chief Legal Officer | Nov 15, 2026 | Tax withholding | −976 | $20.07 | $19.59K | 33,129 |
| Shannon Marie Hansen EVP & Chief Legal Officer | Nov 15, 2026 | Option exercise | +1,917 | – | – | 34,105 |
| Shannon Marie Hansen EVP & Chief Legal Officer | Nov 15, 2026 | Tax withholding | −559 | $20.07 | $11.22K | 32,188 |
| Shannon Marie Hansen EVP & Chief Legal Officer | Nov 15, 2026 | Option exercise | +1,097 | – | – | 32,747 |
| Elizabeth Anne Gasser EVP, Chief Strategy Officer | Nov 15, 2026 | Tax withholding | −1,029 | $20.07 | $20.65K | 2,792 |
| Elizabeth Anne Gasser EVP, Chief Strategy Officer | Nov 15, 2026 | Option exercise | +1,917 | – | – | 3,821 |
| Elizabeth Anne Gasser EVP, Chief Strategy Officer | Nov 15, 2026 | Tax withholding | −589 | $20.07 | $11.82K | 1,904 |
| Elizabeth Anne Gasser EVP, Chief Strategy Officer | Nov 15, 2026 | Option exercise | +1,097 | – | – | 2,493 |
| Rick Carpenter EVP & Chief Technology Officer | Nov 15, 2026 | Tax withholding | −819 | $20.07 | $16.44K | 33,378 |
| Rick Carpenter EVP & Chief Technology Officer | Nov 15, 2026 | Option exercise | +1,609 | – | – | 34,197 |
| Rick Carpenter EVP & Chief Technology Officer | Nov 15, 2026 | Tax withholding | −457 | $20.07 | $9.17K | 32,588 |
| Rick Carpenter EVP & Chief Technology Officer | Nov 15, 2026 | Option exercise | +897 | – | – | 33,045 |
| Sandra Beaver Director | Nov 15, 2026 | Option exercise | +6,747 | – | – | 6,747 |
| Christopher J. Twomey Director | Oct 27, 2026 | Sale(10b5-1 plan) | −1,700 | $19.15 | $32.56K | 24,434 |
| Christopher J. Twomey Director | Oct 27, 2026 | Option exercise | +1,700 | $19.00 | $32.30K | 26,134 |
| Jean-Claude Kyrillos EVP & Chief Operating Officer | Oct 15, 2026 | Tax withholding | −1,926 | $16.52 | $31.82K | 32,001 |
| Jean-Claude Kyrillos EVP & Chief Operating Officer | Oct 15, 2026 | Option exercise | +3,637 | – | – | 33,927 |
| Leigh Vosseller EVP & CHIEF FINANCIAL OFFICER | Aug 15, 2026 | Option exercise | +1,496 | – | – | 50,895 |
| Leigh Vosseller EVP & CHIEF FINANCIAL OFFICER | Aug 15, 2026 | Tax withholding | −537 | $22.72 | $12.20K | 50,358 |
| Leigh Vosseller EVP & CHIEF FINANCIAL OFFICER | Aug 15, 2026 | Option exercise | +2,624 | – | – | 52,982 |
| Leigh Vosseller EVP & CHIEF FINANCIAL OFFICER | Aug 15, 2026 | Tax withholding | −942 | $22.72 | $21.40K | 52,040 |
| Elizabeth Anne Gasser EVP, Chief Strategy Officer | Aug 15, 2026 | Option exercise | +1,917 | – | – | 2,425 |
| Elizabeth Anne Gasser EVP, Chief Strategy Officer | Aug 15, 2026 | Tax withholding | −589 | $22.72 | $13.38K | 508 |
| Elizabeth Anne Gasser EVP, Chief Strategy Officer | Aug 15, 2026 | Option exercise | +1,097 | – | – | 1,097 |
| Elizabeth Anne Gasser EVP, Chief Strategy Officer | Aug 15, 2026 | Tax withholding | −1,029 | $22.72 | $23.38K | 1,396 |
| Susan Morrison EVP & Chief Admin. Officer | Aug 15, 2026 | Tax withholding | −495 | $22.72 | $11.25K | 52,788 |
| Susan Morrison EVP & Chief Admin. Officer | Aug 15, 2026 | Option exercise | +1,730 | – | – | 53,283 |
| Susan Morrison EVP & Chief Admin. Officer | Aug 15, 2026 | Option exercise | +1,097 | – | – | 51,867 |
| Susan Morrison EVP & Chief Admin. Officer | Aug 15, 2026 | Tax withholding | −314 | $22.72 | $7.13K | 51,553 |
| Shannon Marie Hansen EVP & Chief Legal Officer | Aug 15, 2026 | Option exercise | +1,097 | – | – | 31,268 |
| Shannon Marie Hansen EVP & Chief Legal Officer | Aug 15, 2026 | Tax withholding | −559 | $22.72 | $12.70K | 30,709 |
| Shannon Marie Hansen EVP & Chief Legal Officer | Aug 15, 2026 | Option exercise | +1,917 | – | – | 32,626 |
| Shannon Marie Hansen EVP & Chief Legal Officer | Aug 15, 2026 | Tax withholding | −976 | $22.72 | $22.17K | 31,650 |
| John F. Sheridan PRESIDENT & CEO, Director | Aug 15, 2026 | Option exercise | +5,982 | – | – | 158,425 |
| John F. Sheridan PRESIDENT & CEO, Director | Aug 15, 2026 | Tax withholding | −3,044 | $22.72 | $69.16K | 155,381 |
| John F. Sheridan PRESIDENT & CEO, Director | Aug 15, 2026 | Option exercise | +9,934 | – | – | 165,315 |
| John F. Sheridan PRESIDENT & CEO, Director | Aug 15, 2026 | Tax withholding | −5,055 | $22.72 | $114.85K | 160,260 |
| Rick Carpenter EVP & Chief Technology Officer | Aug 15, 2026 | Option exercise | +1,610 | – | – | 32,968 |
| Rick Carpenter EVP & Chief Technology Officer | Aug 15, 2026 | Tax withholding | −457 | $22.72 | $10.38K | 31,358 |
| Rick Carpenter EVP & Chief Technology Officer | Aug 15, 2026 | Option exercise | +897 | – | – | 31,815 |
| Rick Carpenter EVP & Chief Technology Officer | Aug 15, 2026 | Tax withholding | −820 | $22.72 | $18.63K | 32,148 |
| Jean-Claude Kyrillos EVP & Chief Operating Officer | Aug 15, 2026 | Tax withholding | −535 | $22.72 | $12.16K | 30,290 |
| Jean-Claude Kyrillos EVP & Chief Operating Officer | Aug 15, 2026 | Option exercise | +1,010 | – | – | 30,825 |
| Jean-Claude Kyrillos EVP & Chief Operating Officer | Jul 15, 2026 | Tax withholding | −1,926 | $15.28 | $29.43K | 29,815 |
| Jean-Claude Kyrillos EVP & Chief Operating Officer | Jul 15, 2026 | Option exercise | +3,636 | – | – | 31,741 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Tandem Diabetes Care's stock actually held short. Settlement fails (shares not delivered on time) peaked at 22,161 shares on Oct 9, 2026 over the last 90 days.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Christopher J. Twomey Director | Oct 27, 2026 | 1,700 | $32.13K | Oct 27, 2026 | Exercise of Stock Options |
| Mark David Novara Officer | Sep 17, 2026 | 360 | $6.31K | Sep 17, 2026 | Restricted Stock Units |
| Mark David Novara Officer | Aug 18, 2026 | 131 | $2.92K | Aug 18, 2026 | Restricted Stock Units |
| Mark David Novara Officer | Jun 17, 2026 | 361 | $6.03K | Jun 17, 2026 | Restricted Stock Units |
| Mark David Novara Officer | May 19, 2026 | 266 | $3.60K | May 19, 2026 | Restricted Stock Units |
| Mark David Novara Officer | Mar 17, 2026 | 187 | $4.10K | Mar 17, 2026 | Restricted Stock Units |
| Mark David Novara Officer | Mar 5, 2026 | 2 | $47 | Mar 5, 2026 | Restricted Stock Units |
| Kim D. Blickenstaff Board of Directors, Chair Emeritus | Nov 21, 2024 | 30,000 | $900.00K | Nov 21, 2024 | Purchase |
| Kim D. Blickenstaff Board of Directors Chair Emeritus | Nov 20, 2024 | 10,000 | $1.20M | Nov 20, 2024 | PURCHASE |
Congress trades
8 trades in Tandem Diabetes Care reported by 4 members of the House
| Member | Type | Traded | Amount | Filed |
|---|---|---|---|---|
| Gilbert Cisneros CA31 | Bought | Sep 29, 2026 | $1K–15K | Oct 12, 2026 |
| Gilbert Cisneros CA31 | Bought | Mar 3, 2026 | $1K–15K | Apr 7, 2026 |
| Josh Gottheimer NJ05 · joint account | Bought | Sep 22, 2025 | $1K–15K | Oct 15, 2025 |
| Josh Gottheimer NJ05 · joint account | Sold | Mar 19, 2025 | $1K–15K | Apr 10, 2025 |
| Gilbert Cisneros CA31 | Bought | Mar 4, 2025 | $1K–15K | Apr 7, 2025 |
| Josh Gottheimer NJ05 · joint account | Bought | Aug 5, 2024 | $1K–15K | Sep 11, 2024 |
| Daniel Goldman NY10 | Sold | Jul 12, 2023 | $1K–15K | Aug 13, 2023 |
| Thomas MacArthur NJ03 · joint account | Sold | May 27, 2015 | $1K–15K | Jun 7, 2015 |
See a number that looks wrong?